EUCTR2007-004879-19-EE进行中（未招募）不适用
A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction (EIB) in Pediatric Patients Aged 4 to 14 Years
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The child is 4 years to 14 years of age. The child has exercise-induced bronchoconstriction (EIB) with or without a diagnosis of persistent asthma.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •The child has active or chronic breathing disease, other than asthma. The child has required insertion of a breathing tube for asthma. The child had major surgery within the last 4 weeks. The child is currently in the hospital. The child has or had an upper respiratory tract infection within the last 2 weeks. The child has been hospitalized or visited the emergency room or had a change in their medication for asthma within the last 4 weeks. The child has been in a research study in the last 4 weeks. The child has stomach, brain, heart, kidney or liver disease. The child drinks more that 4 caffeinated drinks a day. The child is hypersensitive to inhaled ß-agonist or montelukast.
研究者
相似试验
已完成
2 期
A Clinical Trial to study the Effect of TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia.CTRI/2009/091/001040TargaceptInc185
进行中（未招募）
不适用
A Double-Blind, Placebo-Controlled, Multicenter, Dose-ranging Study of an Anti-T-lymphocyte Immunglobuline (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s)Patients with end-stage pulmonary failure, who are receiving a primary single or double pulmonary allograftEUCTR2005-001131-30-ATFresenius Biotech North America220
进行中（未招募）
1 期
A Placebo-Controlled, Multicenter, Double-Blind, Randomized, Pharmacokinetic and Pharmacodynamic Trial of IDN-6556 in Subjects with Acute-on-Chronic Liver FailureAcute-on-Chronic Liver FailureEUCTR2012-004245-33-GBConatus Pharmaceuticals Inc.21
进行中（未招募）
不适用
A Clinical Study of the Safety and Efficacy of Natalizumab in Acute Ischemic StrokeAcute Ischemic StrokeMedDRA version: 16.1Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 100000004852EUCTR2013-001514-15-ESBiogen Idec Research Limited200
进行中（未招募）
1 期
A Clinical Study of the Safety and Efficacy of Natalizumab in Acute Ischemic StrokeEUCTR2015-004783-11-ESBiogen Idec Research Limited240